Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Zomedica Corp. turns revenue into operating income and net income.
| Metric | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $32.03M | $27.29M | $25.19M | $18.93M | $4.13M | $0 | $0 | $0 | $0 | $0 |
| Revenue Growth? | +17.4% | +8.3% | +33.0% | +358.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $10.35M | $8.20M | $7.87M | $5.28M | $1.08M | $530,020 | $787,613 | $205,767 | $92,410 | $45,821 |
| Gross Profit? | $21.68M | $19.09M | $17.32M | $13.65M | $3.05M | -$530,020 | -$787,613 | -$205,767 | -$92,410 | -$45,821 |
| Gross Margin? | +67.7% | +70.0% | +68.8% | +72.1% | +73.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $50.20M | $70.14M | $48.91M | $35.58M | $24.43M | $16.76M | $19.78M | $16.58M | $8.08M | $6.00M |
| Operating Income? | -$84.35M | -$51.05M | -$31.59M | -$21.92M | -$21.37M | -$16.76M | -$19.78M | -$16.58M | -$8.08M | -$6.00M |
| EBITDA? | -$84.35M | -$39.55M | -$29.39M | -$15.34M | -$19.57M | -$16.38M | -$19.00M | -$16.44M | -$7.97M | -$5.97M |
| Income Before Tax | -$82.14M | -$47.54M | -$35.86M | -$19.38M | -$20.72M | -$16.91M | -$19.78M | -$16.65M | -$8.07M | -$6.01M |
| Income Tax Expense | -$278,000 | -$557,000 | -$1.33M | -$2.37M | -$2.33M | $0 | $0 | $136,882 | -$18,978 | $28,592 |
| Net Income? | -$81.86M | -$46.98M | -$34.53M | -$17.02M | -$18.38M | -$16.92M | -$19.82M | -$16.65M | -$8.07M | -$6.01M |
| EPS? | $-0.08 | $-0.05 | $-0.04 | $-0.02 | $-0.02 | $-0.05 | $-0.19 | $-0.18 | $-0.09 | $-0.07 |
| Diluted EPS? | $-0.08 | $-0.05 | $-0.04 | $-0.02 | $-0.02 | $-0.05 | $-0.19 | $-0.18 | $-0.09 | $-0.07 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality